Edition:
United States

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

22.69USD
21 Nov 2017
Change (% chg)

-- (--)
Prev Close
$22.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
99,050
52-wk High
$33.21
52-wk Low
$21.53

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Stephen Tullman

51 2012 Chairman of the Board

Neal Walker

47 2012 President, Chief Executive Officer, Director

Frank Ruffo

51 2012 Chief Financial Officer, Secretary

Christopher Powala

57 2012 Chief Operating Officer

Stuart Shanler

56 2012 Chief Scientific Officer